Dolutegravir-based antiretroviral therapy and hypertensive-disorder risk in pregnant women with HIV: a target-trial emulation of regimen-timing effects on severe maternal morbidity

Chikwanha, Amara N., Moyo, Tendai M.

Open source

DOI
10.5281/zenodo.23920390
Published
2026
Container
Not recorded
Publisher
Zenodo
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.23920390,
  title = {Dolutegravir-based antiretroviral therapy and hypertensive-disorder risk in pregnant women with HIV: a target-trial emulation of regimen-timing effects on severe maternal morbidity},
  author = {Chikwanha, Amara N. and Moyo, Tendai M.},
  year = {2026},
  doi = {10.5281/zenodo.23920390},
  url = {https://doi.org/10.5281/zenodo.23920390}
}

RIS

TY  - JOUR
TI  - Dolutegravir-based antiretroviral therapy and hypertensive-disorder risk in pregnant women with HIV: a target-trial emulation of regimen-timing effects on severe maternal morbidity
AU  - Chikwanha, Amara N.
AU  - Moyo, Tendai M.
PY  - 2026
DO  - 10.5281/zenodo.23920390
UR  - https://doi.org/10.5281/zenodo.23920390
ER  - 

APA

N., C. A., & M., M. T. (2026). Dolutegravir-based antiretroviral therapy and hypertensive-disorder risk in pregnant women with HIV: a target-trial emulation of regimen-timing effects on severe maternal morbidity. https://doi.org/10.5281/zenodo.23920390

Source records